<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05620108</url>
  </required_header>
  <id_info>
    <org_study_id>22-009153</org_study_id>
    <nct_id>NCT05620108</nct_id>
  </id_info>
  <brief_title>Intubating Conditions of Neuromuscular Blockade</brief_title>
  <official_title>Intubating Conditions at Various Levels of Neuromuscular Blockade</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this research is to learn about the difference in the endotracheal intubation&#xD;
      condition (ease of using a device to view vocal cords, position of vocal cords, and patient's&#xD;
      reaction to endotracheal tube insertion) and determining the appropriate time to perform the&#xD;
      intubation.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">November 28, 2022</start_date>
  <completion_date type="Anticipated">December 2023</completion_date>
  <primary_completion_date type="Anticipated">December 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Assessment of the intubating conditions</measure>
    <time_frame>Approximately 15 minutes after intubation</time_frame>
    <description>Evaluated by the healthcare providers using a scale that includes 4 variables (ease of laryngoscopy, vocal cord position, and reaction to tracheal tube insertion) with 3 response options per each evaluation. The composite score (1-3) will used, with the lowest total score of 3 correlating with optimal intubating conditions and the highest score of 9 representing the worse possible intubating conditions.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">170</enrollment>
  <condition>Endotracheal Intubation</condition>
  <arm_group>
    <arm_group_label>Intubation at TOFC=1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects scheduled for an elective surgical procedure will have endotracheal intubation performed when muscles are almost relaxed and monitoring shows only a single count of muscle twitch (in response to a monitor that assesses muscle relaxation)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intubation 2 minutes after rocuronium administration</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects scheduled for an elective surgical procedure will have endotracheal intubation performed 2 minutes after the anesthesia provider gives muscle relaxing medication</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Endotracheal Intubation at TOFC=1</intervention_name>
    <description>Intubation using a video laryngoscopy will be performed after train-of-four (TOFC) stimulation indicates neuromuscular blockade</description>
    <arm_group_label>Intubation at TOFC=1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Endotracheal Intubation 2 minutes after rocuronium administration</intervention_name>
    <description>Intubation using a video laryngoscopy will be performed 2 minutes after administration of rocuronium at 0.6 mg/kg (usual current clinical routine)</description>
    <arm_group_label>Intubation 2 minutes after rocuronium administration</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients willing to participate and provide an informed consent.&#xD;
&#xD;
          -  Patients undergoing elective surgical procedures that require use of NMBA agents&#xD;
             (rocuronium) administered intraoperatively.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with disorders, such as stroke, carpal tunnel syndrome, broken wrist with&#xD;
             nerve damage, Dupuytren contracture, or any similar wrist injury.&#xD;
&#xD;
          -  Patients with systemic neuromuscular diseases such as myasthenia gravis.&#xD;
&#xD;
          -  Patients with significant organ dysfunction that can significantly affect&#xD;
             pharmacokinetics of neuromuscular blocking and reversal agents; i.e., severe renal&#xD;
             impairment or end-stage liver disease.&#xD;
&#xD;
          -  Patients having surgery that would involve prepping the arm into the sterile field.&#xD;
&#xD;
          -  Patients receiving a rapid sequence induction.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>J. Ross Renew, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mayo Clinic Florida</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32223</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.mayo.edu/research/clinical-trials</url>
    <description>Mayo Clinic Clinical Trials</description>
  </link>
  <verification_date>November 2022</verification_date>
  <study_first_submitted>November 9, 2022</study_first_submitted>
  <study_first_submitted_qc>November 9, 2022</study_first_submitted_qc>
  <study_first_posted type="Actual">November 17, 2022</study_first_posted>
  <last_update_submitted>November 28, 2022</last_update_submitted>
  <last_update_submitted_qc>November 28, 2022</last_update_submitted_qc>
  <last_update_posted type="Actual">November 29, 2022</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>J. Ross Renew, M.D.</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rocuronium</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

